---
title: "Sorrento Therapeutics, Inc. (SRNE.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SRNE.US/norm.md"
symbol: "SRNE.US"
name: "Sorrento Therapeutics, Inc."
parent: "https://longbridge.com/en/quote/SRNE.US.md"
datetime: "2026-03-04T03:42:14.498Z"
locales:
  - [en](https://longbridge.com/en/quote/SRNE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SRNE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SRNE.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SRNE.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SRNE.US/norm.md)


# Sorrento Therapeutics, Inc. (SRNE.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 |
| --- | --- | --- | --- | --- |
| EPS | -0.1727 | -0.2600 | -0.5431 | -0.1211 |
| ROE | 230.39% | 775.09% | -488.08% | -106.95% |
| Revenue | 15.03M | 16.25M | 11.46M | 18.39M |
| Net income | -95.21M | -139.62M | -218.76M | -40.81M |
| Operating income | -76.77M | -88.85M | -91.88M | -96.71M |
| Gross margin | -177.70% | -201.46% | -372.65% | -279.30% |
| Net margin | -633.69% | -859.12% | -1908.73% | -222.00% |
| Profit quality | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 |
| --- | --- | --- | --- | --- |
| A&L | 456.69M | 460.06M | 632.13M | 855.64M |
| Leverage | -2.31 | -3.61 | 4.66 | 3.78 |
| BVPS | -0.3772 | -0.2308 | 0.3079 | 0.6163 |
| Turnover | 0.1181 | 0.0923 | 0.0779 | 0.0776 |
| Cash & STI | 80.64M | 50.32M | 133.60M | 270.66M |
| Inv & Rec | 9.65M | 11.31M | 20.70M | 14.09M |
| LT assets | 106.64M | 140.26M | 128.62M | 126.60M |
| Net debt | 126.97M | 119.23M | 71.00M | -21.77M |

## Cash Flow Statement (USD)

| Indicator | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 |
| --- | --- | --- | --- | --- |
| Operating CF | -55.66M | -49.46M | -80.99M | -83.36M |
| Investing CF | -140000.00 | 1.68M | -1.73M | -13.66M |
| Financing CF | 88.81M | 61.20M | 41.77M | 173.37M |
| Free CF | -6.08M | -169.48M | -82.67M | -14.40M |
| OCF coverage | -2962.16% | -1357.64% | -123.22% | -163.74% |
| Repaid & issued | 76.21M | 41.78M | -28000.00 | 57.12M |
| CapEx | -140000.00 | -86000.00 | -2.71M | -2.59M |